- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 31, 2026 | 5.49M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 1.18M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 891.44K sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$6.9M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $3.56M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $13.27M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $6.09M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$3.12M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$3.24M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $58.84M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $61.95M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $60.56M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $64.68M |
| Current Assets | FY 2025 · Dec 31, 2025 | $27.49M |
| Current Assets | FY 2025 · Dec 31, 2024 | $26.01M |
| Total Assets | FY 2025 · Dec 31, 2025 | $57.44M |
| Total Assets | FY 2025 · Dec 31, 2024 | $61.44M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$20.11 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$51.75 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$20.11 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$51.75 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $22.65M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $18.31M |
| Net Income | FY 2025 · Dec 31, 2025 | −$23.66M |
| Net Income | FY 2025 · Dec 31, 2024 | −$46.13M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$19.29M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$31.15M |
| Gross Profit | FY 2025 · Dec 31, 2025 | $17.34M |
| Gross Profit | FY 2025 · Dec 31, 2024 | $20.28M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $22.41M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $38.99M |
| Revenue | FY 2025 · Dec 31, 2025 | $39.75M |
| Revenue | FY 2025 · Dec 31, 2024 | $59.27M |